Long non-coding RNA expression in bladder cancer

Cao Q, Wang N, Qi J, Gu Z, Shen H (2016) Long non-coding RNA-GAS5 acts as a tumor suppressor in bladder transitional cell carcinoma via regulation of chemokine (C-C motif) ligand 1 expression. Mol Med Rep 13:27–34

Chen M, Zhuang C, Liu Y, Li J, Dai F, Xia M, Zhan Y, Lin J, Chen Z, He A, Xu W, Zhao G, Guo Y, Cai Z, Huang W (2016a) Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer. Canc Lett 376:155–164. https://doi.org/10.1016/j.canlet.2016.03.037

Chen T, Xie W, Xie L, Sun Y, Zhang Y, Shen Z, Sha N, Xu H, Wu Z, Hu H, Wu C (2015) Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer. Biochem Biophys Res Commun 468:666–670. https://doi.org/10.1016/j.bbrc.2015.11.013

Chen Z, Liu Y, He A, Li J, Chen M, Zhan Y, Lin J, Zhuang C, Liu L, Zhao G, Huang W, Cai Z (2016b) Theophylline controllable RNAi-based genetic switches regulate expression of lncRNA TINCR and malignant phenotypes in bladder cancer cells. Sci Rep 6:30798. https://doi.org/10.1038/srep30798

Dianatpour A, Ghafouri-Fard S (2017) The role of long non coding RNAs in the repair of DNA double strand breaks. Int J Mol Cell Med 6:1–12

Duan W, Du L, Jiang X, Wang R, Yan S, Xie Y, Yan K, Wang Q, Wang L, Zhang X, Pan H, Yang Y, Wang C (2016) Identification of a serum circulating lncRNA panel for the diagnosis and recurrence prediction of bladder cancer. Oncotarget 7:78850–78858. https://doi.org/10.18632/oncotarget.12880

Fan Y, Shen B, Tan M, Mu X, Qin Y, Zhang F, Liu Y (2014) TGF-β–induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin Canc Res 20:1531–1541

Ghafouri-Fard S, Nekoohesh L, Motevaseli E (2014) Bladder cancer biomarkers: review and update. Asian Pac J Canc Prev 15:2395–2403

Greife A, Knievel J, Ribarska T, Niegisch G, Schulz WA (2014) Concomitant downregulation of the imprinted genes DLK1 and MEG3 at 14q32.2 by epigenetic mechanisms in urothelial carcinoma. Clin Epigenet 6:29. https://doi.org/10.1186/1868-7083-6-29

Guttman M, Rinn JL (2012) Modular regulatory principles of large non-coding RNAs. Nature 482:339–346. https://doi.org/10.1038/nature10887

He AB, Chen ZC, Mei HB, Liu YC (2016a) Decreased expression of LncRNA MIR31HG in human bladder cancer. Canc Biomark 17:231–236. https://doi.org/10.3233/Cbm-160635

He AB, Liu Y, Chen Z, Li J, Chen M, Liu L, Liao X, Lv Z, Zhan Y, Zhuang C, Lin J, Huang W, Mei H (2016b) Over-expression of long noncoding RNA BANCR inhibits malignant phenotypes of human bladder cancer. J Exp Clin Canc Res 35:125. https://doi.org/10.1186/S13046-016-0397-9

Huang XX, Xiao R, Pan S, Yang X, Yuan W, Tu Z, Xu M, Zhu Y, Yin Q, Wu Y, Hu W, Shao L, Xiong J, Zhang Q (2017) Uncovering the roles of long non-coding RNAs in cancer stem cells. J Hematol Oncol 10:62. https://doi.org/10.1186/s13045-017-0428-9

Iliev R, Kleinova R, Juracek J, Dolezel J, Ozanova Z, Fedorko M, Pacik D, Svoboda M, Stanik M, Slaby O (2016) Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer. Tumor Biol 37:13385–13390. https://doi.org/10.1007/s13277-016-5177-9

Iranpour M, Soudyab M, Geranpayeh L, Mirfakhraie R, Azargashb E, Movafagh A, Ghafouri-Fard S (2016) Expression analysis of four long noncoding RNAs in breast cancer. Tumor Biol 37:2933–2940. https://doi.org/10.1007/s13277-015-4135-2

Khorshidi HR, Taheri M, Noroozi R, Sarrafzadeh S, Sayad A, Ghafouri-Fard S (2017a) ANRIL genetic variants in Iranian breast cancer patients. Cell J 19:72–78. https://doi.org/10.22074/cellj.2017.4496

Khorshidi HR, Taheri M, Noroozi R, Soudyab M, Sayad A, Ghafouri-Fard S (2017b) Investigation of the association of HOTAIR single nucleotide polymorphisms and risk of breast cancer in an Iranian population. Int J Canc Manag 10:e7498. https://doi.org/10.5812/ijcm.7498

Kretz M, Siprashvili Z, Chu C, Webster DE, Zehnder A, Qu K, Lee CS, Flockhart RJ, Groff AF, Chow J, Johnston D, Kim GE, Spitale RC, Flynn RA, Zheng GX, Aiyer S, Raj A, Rinn JL, Chang HY, Khavari PA (2013) Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 493:231–235. https://doi.org/10.1038/nature11661

Li C, Cui Y, Liu LF, Ren WB, Li QQ, Zhou X, Li YL, Li Y, Bai XY, Zu XB (2017) High expression of long non-coding RNA MALAT1 indicates a poor prognosis and promotes clinical progression and metastasis in bladder cancer. Clin Genitourin Canc 15:570–576. https://doi.org/10.1016/j.clgc.2017.05.001

Li J, Zhuang C, Liu Y, Chen M, Zhou Q, Chen Z, He A, Zhao G, Guo Y, Wu H, Cai Z, Huang W (2016) shRNA targeting long non-coding RNA CCAT2 controlled by tetracycline-inducible system inhibits progression of bladder cancer cells. Oncotarget 7:28989–28997. https://doi.org/10.18632/oncotarget.8259

Li LJ, Zhu JL, Bao WS, Chen DK, Huang WW, Weng ZL (2014) Long noncoding RNA GHET1 promotes the development of bladder cancer. Int J Clin Exp Pathol 7:7196–7205

Liu Q, Liu H, Cheng H, Li Y, Li X, Zhu C (2017) Downregulation of long noncoding RNA TUG1 inhibits proliferation and induces apoptosis through the TUG1/miR-142/ZEB2 axis in bladder cancer cells. OncoTarget Ther 10:2461–2471. https://doi.org/10.2147/ott.s124595

Liu Z, Wang W, Jiang J, Bao E, Xu D, Zeng Y, Tao L, Qiu J (2013) Downregulation of GAS5 promotes bladder cancer cell proliferation, partly by regulating CDK6. PLoS ONE 8:e73991

Luo M, Li Z, Wang W, Zeng Y, Liu Z, Qiu J (2013a) Upregulated H19 contributes to bladder cancer cell proliferation by regulating ID2 expression. FEBS J 280:1709–1716

Luo M, Li ZW, Wang W, Zeng YG, Liu ZH, Qiu JX (2013b) Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. Canc Lett 333:213–221. https://doi.org/10.1016/j.canlet.2013.01.033

Nikpayam E, Soudyab M, Tasharrofi B, Sarrafzadeh S, Iranpour M, Geranpayeh L, Mirfakhraie R, Gharesouran J, Ghafouri-Fard S (2017a) Expression analysis of long non-coding ATB and its putative target in breast cancer. Breast Dis 1-10

Nikpayam E, Tasharrofi B, Sarrafzadeh S, Ghafouri-Fard S (2017b) The role of long non-coding RNAs in ovarian cancer. Iran Biomed J 21:3–15

Peter S, Borkowska E, Drayton RM, Rakhit CP, Noon AP, Chen W, Catto JW (2014) Identification of differentially expressed long non-coding RNAs in bladder cancer. Clin Canc Res 7:78850–78858. https://doi.org/10.18632/oncotarget.12880

Qi P, Xu MD, Ni SJ, Shen XH, Wei P, Huang D, Tan C, Sheng WQ, Zhou XY, Du X (2015) Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients. Mol Carcinogen 54:742–750. https://doi.org/10.1002/mc.22137

Sarrafzadeh S, Geranpayeh L, Ghafouri-fard S (2017a) Expression analysis of long non-coding PCAT-1. Int J Hematol Oncol Stem Cell Res 11:185–191

Sarrafzadeh S, Geranpayeh L, Tasharrofi B, Soudyab M, Nikpayam E, Iranpour M, Mirfakhraie R, Gharesouran J, Ghafouri-Fard S, Ghafouri-Fard S (2017b) Expression study and clinical correlations of MYC and CCAT2 in breast cancer patients. Iran Biomed J 21:303–311

Soudyab M, Iranpour M, Ghafouri-Fard S (2016) The role of long non-coding RNAs in breast cancer. Arch Iran Med 19: 508-517. Doi: 0161907/AIM.0011

Sun L, Xue H, Jiang C, Zhou H, Gu L, Liu Y, Xu C, Xu Q (2016) LncRNA DQ786243 contributes to proliferation and metastasis of colorectal cancer both in vitro and in vivo. Biosci Rep 36. https://doi.org/10.1042/BSR20160048

Sun X, Du P, Yuan W, Du Z, Yu M, Yu X, Hu T (2015) Long non-coding RNA HOTAIR regulates cyclin J via inhibition of microRNA-205 expression in bladder cancer. Cell Death Dis 6:e1907. https://doi.org/10.1038/cddis.2015.269

Tabarestani S, Ghafouri-Fard S (2012) Cancer stem cells and response to therapy. Asian Pac J Canc Prev 13:5947–5954

Taheri M, Habibi M, Noroozi R, Rakhshan A, Sarrafzadeh S, Sayad A, Omrani MD, Ghafouri-Fard S (2017a) HOTAIR genetic variants are associated with prostate cancer and benign prostate hyperplasia in an Iranian population. Gene 613:20–24

Taheri M, Pouresmaeili F, Omrani MD, Habibi M, Sarrafzadeh S, Noroozi R, Rakhshan A, Sayad A, Ghafouri-Fard S (2017b) Association of ANRIL gene polymorphisms with prostate cancer and benign prostatic hyperplasia in an Iranian population. Biomark Med 11:413–422

Tan J, Qiu K, Li M, Liang Y (2015) Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells. FEBS Lett 589:3175–3181

Tasharrofi B, Soudyab M, Nikpayam E, Iranpour M, Mirfakhraie R, Sarrafzadeh S, Geranpayeh L, Azargashb E, Sayad A, Ghafouri-Fard S (2016) Comparative expression analysis of hypoxia-inducible factor-alpha and its natural occurring antisense in breast cancer tissues and adjacent noncancerous tissues. Cell Biochem Func 34:572–578

Wang Y-Y, Wu Z-Y, Wang G-C, Liu K, Niu X-B, Gu S, Meng J-S (2016) LINC00312 inhibits the migration and invasion of bladder cancer cells by targeting miR-197-3p. Tumor Biol 37:14553–14563

XianGuo C, ZongYao H, Jun Z, Song F, GuangYue L, LiGang Z, KaiPing Z, YangYang Z, ChaoZhao L (2016) Promoting progression and clinicopathological significance of NEAT1 over-expression in bladder cancer. Oncotarget. https://doi.org/10.18632/oncotarget.10084

Xue Y, Ma G, Zhang Z, Hua Q, Chu H, Tong N, Yuan L, Qin C, Yin C, Zhang Z, Wang M (2015) A novel antisense long noncoding RNA regulates the expression of MDC1 in bladder cancer. Oncotarget 6:484–493

Ye T, Ding W, Wang N, Huang H, Pan Y, Wei A (2017) Long noncoding RNA linc00346 promotes the malignant phenotypes of bladder cancer. Biochem Biophys Res Commun 491:79–84. https://doi.org/10.1016/j.bbrc.2017.07.045

Ying L, Chen Q, Wang Y, Zhou Z, Huang Y, Qiu F (2012) Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. Mol BioSyst 8:2289–2294

Ying L, Huang Y, Chen H, Wang Y, Xia L, Chen Y, Liu Y, Qiu F (2013) Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer. Mol BioSyst 9:407–411. https://doi.org/10.1039/c2mb25386k

Zhan YH, Lin J, Liu Y, Chen M, Chen X, Zhuang C, Liu L, Xu W, Chen Z, He A, Zhang Q, Sun X, Zhao G, Huang W (2016a) Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer. J Exp Clin Canc Res 35:83. https://doi.org/10.1186/s13046-016-0354-7

Zhan YH, Liu Y, Wang C, Lin J, Chen M, Chen X, Zhuang C, Liu L, Xu W, Zhou Q, Sun X, Zhang Q, Zhao G, Huang W (2016b) Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer. Oncotarget 7:16038–16048

Zhang H, Guo Y, Song Y, Shang C (2017) Long noncoding RNA GAS5 inhibits malignant proliferation and chemotherapy resistance to doxorubicin in bladder transitional cell carcinoma. Canc Chemother Pharmacol 79:49–55

Zhang J, Shi Z, Nan Y, Li M (2016) Inhibiting malignant phenotypes of the bladder cancer cells by silencing long noncoding RNA SChLAP1. Int Urol Nephrol 48:711–716

Zhang QA, Su M, Lu GM, Wang JD (2013) The complexity of bladder cancer: long noncoding RNAs are on the stage. Mol Canc 12:101. https://doi.org/10.1186/1476-4598-12-101

Zhu Y, Dai B, Zhang H, Shi G, Shen Y, Ye D (2016) Long non-coding RNA LOC572558 inhibits bladder cancer cell proliferation and tumor growth by regulating the AKT–MDM2–p53 signaling axis. Canc Lett 380:369–374

Zhu Y, Yu M, Li Z, Kong C, Bi J, Li J, Gao Z, Li Z (2011) ncRAN, a newly identified long noncoding RNA, enhances human bladder tumor growth, invasion, and survival. Urology 77:510 e511-510. e515

Zhuang C, Li J, Liu Y, Chen M, Yuan J, Fu X, Zhan Y, Liu L, Lin J, Zhou Q, Xu W, Zhao G, Cai Z, Huang W (2015) Tetracycline-inducible shRNA targeting long non-coding RNA PVT1 inhibits cell growth and induces apoptosis in bladder cancer cells. Oncotarget 6:41194–41203. https://doi.org/10.18632/oncotarget.5880